Search Results - "Dimberg, Anna"

Refine Results
  1. 1

    Tumor angiogenesis: causes, consequences, challenges and opportunities by Lugano, Roberta, Ramachandran, Mohanraj, Dimberg, Anna

    “…Tumor vascularization occurs through several distinct biological processes, which not only vary between tumor type and anatomic location, but also occur…”
    Get full text
    Journal Article
  2. 2

    The glioblastoma vasculature as a target for cancer therapy by Dimberg, Anna

    Published in Biochemical Society transactions (01-12-2014)
    “…Glioblastoma is characterized by microvascular proliferation and a highly abnormal dysfunctional vasculature. The glioblastoma vessels differ significantly…”
    Get more information
    Journal Article
  3. 3

    Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer by Georganaki, Maria, van Hooren, Luuk, Dimberg, Anna

    Published in Frontiers in immunology (21-12-2018)
    “…Boosting natural immunity against malignant cells has had a major breakthrough in clinical cancer therapy. This is mainly due to the successful development of…”
    Get full text
    Journal Article
  4. 4

    CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis by Lugano, Roberta, Vemuri, Kalyani, Yu, Di, Bergqvist, Michael, Smits, Anja, Essand, Magnus, Johansson, Staffan, Dejana, Elisabetta, Dimberg, Anna

    Published in The Journal of clinical investigation (01-08-2018)
    “…Tumor angiogenesis occurs through regulation of genes that orchestrate endothelial sprouting and vessel maturation, including deposition of a vessel-associated…”
    Get full text
    Journal Article
  5. 5

    Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus by Eriksson, Emma, Milenova, Ioanna, Wenthe, Jessica, Ståhle, Magnus, Leja-Jarblad, Justyna, Ullenhag, Gustav, Dimberg, Anna, Moreno, Raphael, Alemany, Ramon, Loskog, Angelica

    Published in Clinical cancer research (01-10-2017)
    “…Pancreatic cancer is a severe indication with short expected survival despite surgery and/or combination chemotherapeutics. Checkpoint blockade antibodies are…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Complementarity-determining region clustering may cause CAR-T cell dysfunction by Sarén, Tina, Saronio, Giulia, Marti Torrell, Paula, Zhu, Xu, Thelander, Josefin, Andersson, Yasmin, Hofström, Camilla, Nestor, Marika, Dimberg, Anna, Persson, Helena, Ramachandran, Mohanraj, Yu, Di, Essand, Magnus

    Published in Nature communications (10-08-2023)
    “…Chimeric antigen receptor (CAR)-T cell therapy is rapidly advancing as cancer treatment, however, designing an optimal CAR remains challenging. A single-chain…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer by Vaccaro, Alessandra, van de Walle, Tiarne, Ramachandran, Mohanraj, Essand, Magnus, Dimberg, Anna

    Published in Frontiers in immunology (26-10-2023)
    “…Tertiary lymphoid structures (TLS) are lymph node-like aggregates that can form in association with chronic inflammation or cancer. Mature TLS are organized…”
    Get full text
    Journal Article
  13. 13

    CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells by Barbera, Stefano, Raucci, Luisa, Lugano, Roberta, Tosi, Gian Marco, Dimberg, Anna, Santucci, Annalisa, Galvagni, Federico, Orlandini, Maurizio

    “…During angiogenesis, cell adhesion molecules expressed on the endothelial cell surface promote the growth and survival of newly forming vessels. Hence,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma by van de Walle, Tiarne, Vaccaro, Alessandra, Ramachandran, Mohanraj, Pietilä, Ilkka, Essand, Magnus, Dimberg, Anna

    Published in Frontiers in immunology (01-09-2021)
    “…Glioblastoma is the most common and aggressive brain tumor, which is uniformly lethal due to its extreme invasiveness and the absence of curative therapies…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib by Niinivirta, Marjut, Georganaki, Maria, Enblad, Gunilla, Lindskog, Cecilia, Dimberg, Anna, Ullenhag, Gustav J

    Published in BMC cancer (22-04-2020)
    “…Patients with metastatic renal cell cancer (mRCC) are commonly treated with the tyrosine kinase inhibitor sunitinib, which blocks signalling from vascular…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Key molecular alterations in endothelial cells in human glioblastoma uncovered through single-cell RNA sequencing by Xie, Yuan, He, Liqun, Lugano, Roberta, Zhang, Yanyu, Cao, Haiyan, He, Qiyuan, Chao, Min, Liu, Boxuan, Cao, Qingze, Wang, Jianhao, Jiao, Yang, Hu, Yaqin, Han, Liying, Zhang, Yong, Huang, Hua, Uhrbom, Lene, Betsholtz, Christer, Wang, Liang, Dimberg, Anna, Zhang, Lei

    Published in JCI insight (09-08-2021)
    “…Passage of systemically delivered pharmacological agents into the brain is largely blocked by the blood-brain-barrier (BBB), an organotypic specialization of…”
    Get full text
    Journal Article
  20. 20